Zoetis Inc. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Zoetis Inc. (ZTS) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $4.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-12
- Zoetis Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $4.00M, a 33.33% increase from fiscal 2024.
- Zoetis Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $3.00M, a 40.00% decline from fiscal 2023.
- Zoetis Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $5.00M, a 66.67% increase from fiscal 2022.
- Zoetis Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $3.00M, a 50.00% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2025-12-31 | $4.00M 10-K · filed 2026-02-12 |
| 2024-12-31 | $3.00M 10-K · filed 2026-02-12 |
| 2023-12-31 | $5.00M 10-K · filed 2026-02-12 |
| 2022-12-31 | $3.00M 10-K · filed 2025-02-13 |
| 2021-12-31 | $2.00M 10-K · filed 2024-02-13 |
| 2020-12-31 | $3.00M 10-K · filed 2023-02-14 |
| 2019-12-31 | $2.00M 10-K · filed 2022-02-15 |
| 2018-12-31 | $2.00M 10-K · filed 2021-02-16 |
| 2017-12-31 | $3.00M 10-K · filed 2020-02-13 |
| 2016-12-31 | $2.00M 10-K · filed 2019-02-14 |
| 2015-12-31 | $1.00M 10-K · filed 2018-02-15 |
| 2014-12-31 | $1.00M 10-K · filed 2017-02-16 |
| 2013-12-31 | $1.00M 10-K · filed 2016-02-24 |
| 2012-12-31 | $2.00M 10-K · filed 2015-02-27 |
| 2011-12-31 | $0.00 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |